Kinoshita H, Ohishi N, Okazaki A
Drug Metabolism Laboratory, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
Arzneimittelforschung. 1991 May;41(5):568-70.
125I-labelled recombinant human erythropoietin (125I-rh-EPO; CAS for EPO: 11096-26-7) was prepared by using iodo-gen (1,3,4,6-tetrachloro-3,6-diphenylglycouril), which showed a similar immunoreactivity to anti rh-EPO anti-rabbit serum and a similar pharmacokinetics with that of non-labeled rh-EPO.